Drug intelligence / Profile preview

thiamidol + Eucerin

Development stage
Unknown
Lead developer
Beiersdorf
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

**Thiamidol + Eucerin** refers to a combination of topical skincare products developed by Eucerin (a Beiersdorf brand) that contain Thiamidol as the principal active ingredient. Thiamidol (4-butylresorcinol) is a patented compound specifically developed and clinically proven to reduce hyperpigmentation by inhibiting the enzyme tyrosinase, the key enzyme involved in melanin (pigment) biosynthesis. By blocking tyrosinase, Thiamidol effectively reduces melanin production, gradually fading existing pigment spots and preventing their recurrence. Eucerin’s formulations are primarily aimed at treating conditions like melasma, age spots, post-inflammatory hyperpigmentation, and general skin tone irregularities. The combination of Eucerin’s topical technology (carriers such as serums, creams, and SPF products) and Thiamidol enables effective and well-tolerated treatment suitable for all skin types and tones. The Eucerin Thiamidol products show results in as early as two weeks, with significant improvement (up to 75% reduction in pigmentation) in 12 weeks. These products are regarded as both effective and gentle, with fewer side effects compared to commonly used agents like hydroquinone[1][2][3].

Brand names
Eucerin Anti-Pigment Day SPF 30Eucerin DermoPure Triple Effect Serum
Other names
thiamidol combination with EucerinEucerin thiamidol products
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on thiamidol + Eucerin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiamidol + Eucerin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call